CTRI/2019/03/018015尚未招募未知
Comparative study on the Safety and Efficacy of Sodium hyaluronate 2% (Pen Injector) and Restylane Vital (PFS)for skin rejuvenation of dorsal handa
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1.Signed informed consent obtained
- •2.Male or female subjects 25-60 years of age, inclusive.
- •3.Visible signs of skin aging in the hands (e.g. reduced skin elasticity, reduced turgor, actinic elastosis, smaller and larger wrinkles) according to the Investigators opinion.
- •4.Subjects must be cooperative and willing to comply with the instructions and procedures.
排除标准
- •1.Active skin disease, inflammation or related conditions, such as infection, perioral dermatitis, seborrheic eczema and rosacea in the face, hands or décolletage.
- •2.History of or active collagenosis (e.g. systemic lupus, erythematosis, rheumatic arthritis, skin or systemic sclerosis).
- •3.Previous hypersensitivity to hyaluronic acid.
- •4.Concomitant therapy with thrombolytics or anticoagulants, or have taken inhibitors of platelet aggregation, within 2 weeks before the baseline visit.
- •5.History of cancerous or pre-cancerous lesions in the face, hands and décolletage.
- •6.Previous tissue augmenting therapy with non-permanent filler or treatment with botulinum toxin, aesthetic surgical therapy, laser treatment, mesotherapy, or any form of peeling in the face, hands or décolletage within 12 months prior to the baseline visit.
- •7.Use of injectable revitalization preparations (e.g. Hyal System®, Restylane Vital, Hyfil) within 12 months prior to the baseline visit.
- •8.Use of retinoic acid within 6 months prior to the baseline visit.
- •9.Previous or concomitant treatment with chemotherapy, immunosuppressive agents or corticoids.
- •10.History of treatment with permanent filling materials.
- •11.Pregnancy or breast feeding woman or woman of childbearing potential not practicing adequate contraception.
- •12.Participation in any other clinical study within 30 days prior to the baseline visit or plan to participate in another clinical study during this study period.
- •13.Unrealistic expectation with regard to the esthetic results of the treatment.
- •14.Alcohol or drug or medication abuse;
- •15.Protocol non-compliant subjects;
- •16.Any significant laboratory findings
研究者
相似试验
尚未招募
3 期
Topic Oleozon in patients with epidermophytosisEpidermophytosisTineaDermatomycosesMycosesSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesBacterial Infections and MycosesInfectionRPCEC00000289ational Center For Scientific Research300
已完成
不适用
To study and compare the injectable route with nasal route of drug delivery in reducing the heart rate and blood pressure during intubation(When a tube is passed through your mouth before surgery when you are unconscious).CTRI/2021/06/034309Arindam Chatterjee50
已完成
不适用
The comparative study of the efficacy and safety of Simeprevir sodium at investigational stage and after marketing authorizatioChronic hepatitis CJPRN-UMIN000045086Shimane University98
尚未招募
2 期
A clinical trial to study the effects of two drugs, metformin lotion and zinc oxide cream in patients with melasma, a type of facial pigmentatioCTRI/2023/09/057901ITHYAMS
Unknown
不适用
Is spinal anaesthesia more safe and effective than general anaesthesia for open surgery of gall bladder?CTRI/2015/04/005715Dr Ram Bhakta Koju120